CLINICAL_TRIALS
trial_result
· 2016-05-26
Clinical Trial Update: Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277® [Phase 3]
Summary
Open-label extension Phase 3 trial of DiaPep277 for Type 1 diabetes was terminated; results were posted on 2016-05-26.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Andromeda Biotech Ltd. | Conditions: Type 1 Diabetes | Phase 3 | Status: TERMINATED | Results posted: 2016-05-26